BCL6 Monoklonaler Antikörper
BCL6 Monoklonal Antikörper für WB, IHC, Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human
Anwendung
WB, IHC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1E6B1
Kat-Nr. : 66340-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66340-1-PBS bindet in WB, IHC, Indirect ELISA BCL6 und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Maus / IgG1 |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | BCL6 fusion protein Ag15519 |
Vollständiger Name | B-cell CLL/lymphoma 6 |
Berechnetes Molekulargewicht | 706 aa, 79 kDa |
Beobachtetes Molekulargewicht | 85 kDa |
GenBank-Zugangsnummer | BC150184 |
Gene symbol | BCL6 |
Gene ID (NCBI) | 604 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-G-Reinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
BCL6, a zinc finger transcription factor, contains an N-terminal BTB/POZ domain and C-terminal zinc finger DNA-binding motifs and represses transcription of a wide range of target proteins and microRNAs. BCL6 protein has been reported as a master regulator of B lymphocyte development and growth, and altered BCL6 protein expression was implicated in pathogenesis of diverse human hematologic malignancies, especially in the diffuse large B cell lymphoma (DLBCL). BCL6 is required for the development of T follicular helper T cells (TFH), a helper T cell subset required for the formation of mature and productive GCs. BCL6 has also been shown to play important regulatory roles in macrophages.